Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday that the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
"I would love this to be clarified. We come to a deal on trade, boy, this market is up 10 to 15%, but without it's going to be worrisome," Jeremy Siegel says.Marketsread more
The final week of August could be highly volatile as markets fret over the economy and the latest developments in trade wars.Market Insiderread more
Tesla solar energy systems reportedly ignited at an Amazon warehouse in Redlands, California last June, and the Seattle e-commerce titan confirmed that it has no further plans...Technologyread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
Dutch paint maker Akzo Nobel on Wednesday posted flat fourth-quarter core earnings of 240 million euros ($272 million), but marginally beat expectations, and said it expected pressure from rising raw material costs to ease in 2019.
Analysts polled by Reuters had expected earnings before interest, taxes, depreciation and amortisation (EBITDA) for the three months ended Dec. 31 to be at 235 million euros, compared with 240 million euros in the year-ago period.
Sales volume declines in China, which fell 7 percent in the fourth quarter of 2018, are expected to ease, Akzo Bobel said in a statement.
The company maintained current financial goals of a 15 percent return on sales and investment by 2020, Chief Executive Officer Thierry Vanlancker said.
"Demand trends differ per region and segment in an uncertain macro-economic environment," the company said. "Raw material inflation is expected to continue during the first half of 2019, although at a lower rate than 2018."
It said it would continue to pass higher prices on to customers, and cut input costs by 200 million euros by 2020.
Akzo Nobel was affected by all macro-economic factors that have captivated investors in 2018, and would continue to be, in 2019, including the U.S.-China trade war, Britain's plan to leave the European union, and high inflation rates in several developing markets, Vanlancker said.
"We really didn't get any help from anybody," Vanlancker said on a call with reporters.
"We belive that for the first 3-4 months of this year, it's going to be business as usual," he said, with a focus on cost-cutting.
Akzo warded off an acquisition by U.S. peer PPG in 2017 and sold its chemicals arm, representing a third of its business, for 10.1 billion euros in March 2018 to a group of buyers led by Carlyle Group.
It outlined plans for proceeds to shareholders in October by mix of sharebacks and a capital return.
Speaking to CNBC's "Squawk Box Europe" on Wednesday, Vanlancker said the sales volume shift in China was a normalization following a surge in demand in the fourth quarter of 2017.
"Our volume in those markets is exactly the same as what we had in the fourth quarter of 2016, so it is actually a normalizing with some extraordinary effect," he said. "We of course are very vigilant on that, (and) if you look at the rest of our business we see about 1 or 2 percent volume stabilizing and starting to gradually come back."
He added that the company expected the numbers in China to "really get much more normalized in the coming year."